Cell and Gene Therapy Insights

CELL AND GENE THERAPY INSIGHTS

December 2024

Cell and Gene Therapy Insights Vol 10 Issue 11
View Issue

Vol 10 Issue 11

Latest Articles

Simplifying lentiviral downstream processing with a novel affinity resin & robust analytical tools

Simplifying lentiviral downstream processing with a novel affinity resin & robust analytical tools

Chantelle Gaskin, Suzy Brown
8 July
Alison test

Alison test

Alison Thomson
8 July
Test Alison

Test Alison

Alison Thomson, Elisa Manzotti
3 July
Addressing the risk presented by extractables and leachables in cell therapy

Addressing the risk presented by extractables and leachables in cell therapy

Nadine Kolas
19 June
An update on prime editing: recent advances and applications

An update on prime editing: recent advances and applications

Daniela Bischof
31 January
Navigating evolving regulatory CMC guidance in the AAV gene therapy field

Navigating evolving regulatory CMC guidance in the AAV gene therapy field

C Fuentes, C Le Bec, M Brewer et al.
25 January
Addressing the risk presented by extractables and leachables in cell therapy manufacturing

Addressing the risk presented by extractables and leachables in cell therapy manufacturing

Audrey Chang
24 January
An automated, closed system for rapid manufacturing of engineered T cells

An automated, closed system for rapid manufacturing of engineered T cells

Ian Johnston
15 January
Biological & operational considerations for iPSC-derived cell production

Biological & operational considerations for iPSC-derived cell production

Austin Mogen
12 January

Channel content

A payment innovation framework to meet the urgent need in advanced therapies

A payment innovation framework to meet the urgent need in advanced therapies

Mark Trusheim
16 April 2023
Driving the expansion of mRNA into the therapeutic sphere

Driving the expansion of mRNA into the therapeutic sphere

Alejandro Becerra, Andreas Kuhn, Metin Kurtoglu
10 April 2023
Overcoming challenges to CAR-T cell therapies in India

Overcoming challenges to CAR-T cell therapies in India

A Uppal, R Chakrabarti, N Chirmule et al.
8 March 2023
View channel
Key considerations & development of regulatory guidance in CMC

Key considerations & development of regulatory guidance in CMC

David Ordóñez del Valle
10 April 2023
Funding the future: cell & gene therapy development

Funding the future: cell & gene therapy development

Nick Meyers, Neil Fish
27 March 2023
Ultra-rapid microbial detection in cell & gene therapy products: the closest you can be to real-time release

Ultra-rapid microbial detection in cell & gene therapy products: the closest you can be to real-time release

Félix Montero-Julian
26 March 2023
View channel
Alison test

Alison test

Alison Thomson
8 July
Implementing demand & operations planning in clinical cell & gene therapy

Implementing demand & operations planning in clinical cell & gene therapy

Peter Horton
26 January 2023
Optimizing cell proliferation and function for immunotherapy with recombinant growth factors and cytokines

Optimizing cell proliferation and function for immunotherapy with recombinant growth factors and cytokines

Martin Keough
17 September 2022
View channel
Quantifying manufacturing uncertainty and developing digital tools for supply chain optimization

Quantifying manufacturing uncertainty and developing digital tools for supply chain optimization

Maria Papathanasiou
21 May 2023
Designing viral vector clearance studies for CGT products according to ICH Q5A (R2): part 1

Designing viral vector clearance studies for CGT products according to ICH Q5A (R2): part 1

Tareq Jaber
18 May 2023
Designing viral clearance studies for CGT products according to ICH Q5A (R2): part 2

Designing viral clearance studies for CGT products according to ICH Q5A (R2): part 2

Tareq Jaber
18 May 2023
View channel
An update on prime editing: recent advances and applications

An update on prime editing: recent advances and applications

Daniela Bischof
31 January
Navigating evolving regulatory CMC guidance in the AAV gene therapy field

Navigating evolving regulatory CMC guidance in the AAV gene therapy field

C Fuentes, C Le Bec, M Brewer et al.
25 January
An automated, closed system for rapid manufacturing of engineered T cells

An automated, closed system for rapid manufacturing of engineered T cells

Ian Johnston
15 January
View channel
Ultra-rapid microbial detection in cell & gene therapy products: the closest you can be to real-time release

Ultra-rapid microbial detection in cell & gene therapy products: the closest you can be to real-time release

Félix Montero-Julian
26 March 2023
Simplifying lentiviral downstream processing with a novel affinity resin & robust analytical tools

Simplifying lentiviral downstream processing with a novel affinity resin & robust analytical tools

Suzy Brown
14 March 2023
Preclinical safety assessment in therapeutic genome editing

Preclinical safety assessment in therapeutic genome editing

Roberto Nitsch
10 March 2023
View channel
At the cutting edge of AAV capsid engineering

At the cutting edge of AAV capsid engineering

Eric Kelsic, Adrian Veres
30 May 2023
Utilizing AI to drive AAV-based gene delivery to the CNS

Utilizing AI to drive AAV-based gene delivery to the CNS

David Huss
28 May 2023
LNPs and beyond: nanoscale delivery systems in advanced therapy applications

LNPs and beyond: nanoscale delivery systems in advanced therapy applications

Shashank Pinnapireddy
17 May 2023
View channel